Latest Pharmaceutical Industry Insights

CPHI & PMEC China 2024

An Overview to 2023 Pharmaceutical Industry by PharmaSources Experts

The Growth of Vaccines Beyond Infectious Disease

Pharmaceutical Industry in 2024: Flexible Production, Innovative Drugs and Personalized Medicine

Hi there, Content Hub is now available! Keep Yourself in Tune with the Latest industry Dynamics

Becoming Contracted Authors of PharmaSources

hidradenitis suppurativa

What To Expect In The 2024 Pharmaceutical Market

what to expect in the 2024 pharma market

Orelabrutinib: A Novel BTK inhibitor

2024 Medical Breakthroughs: New Hope to Patients

Qv o

Gut Hormone-Based Pharmacotherapies for Obesity

diabetes

Pharma in China >>

Ipsen Invested USD 900 Million to Introduce Sutro Biopharma ADC. Is the ROR1 Target Became the "Sweet Pastry" of ADC? Far-away from the Crowd
May 06, 2024
STRO-003 will be the first ADC candidate drug in Ipsen's portfolios.
From Ruxolitinib to Upadacitinib, the USD 5 billion blue ocean market welcomes a fierce battle of JAK inhibitors Spuer 203
May 06, 2024
Medical System from Incyte has initiated Phase III clinical trials of vitiligo in China.
From CDMO Pharmaceutical Crisaborole First Generic Drug, Look at the Domestic PDE-4 Inhibitor R&D Development Layout Xiaobin
May 06, 2024
The NMPA official website showed that Zhejiang CDMO Pharmaceutical had submitted an application for the marketing application of crisaborole ointment as a generic drug and it was accepted by the Center for Drug Evaluation.

Pharma Experts >>

Depyrogenation tunnel for Glass containers Muhammad Asim Niazi
May 09, 2024
Injectable are one of the highly critical products in the pharmaceutical industry and have more impact than non-injectable or liquid products.

Market News >>

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ. Biotech Newswire
May 09, 2024
Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide in an Oleogel Formulation Using the BrainDos™ Technology Significantly Increases Drug Delivery into Cells Biotech Newswire
May 09, 2024
On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023 Biotech Newswire
May 09, 2024
Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023.

Products Guide >>

Popular Products and Companies at PharmaSources.com (January 2024) PharmaSources
February 23, 2024
Popular Products and Companies at PharmaSources.com
Regulatory Compliance in API Drug Production of Different Countries PharmaSources
January 02, 2024
What Is PGE (Prostaglandin) And the Effects of Prostaglandins PharmaSources
January 02, 2024

Brand Story >>

What companies are developing CNS drugs in China? ChatGTP/PharmaSources
November 08, 2023
Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Advertising Email to: Julia.zhang@imsinoexpo.com

Media Cooperation Email to: Jennifer.Yang@imsinoexpo.com
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Subscribe Join Us

Note: You can unsubscribe from the alerts at any time.